| Code | Name | Last | Change(%) | P/E | Yield (%) | P/E Range | ||
| TSHA | Taysha Gene Therapies |  | 5.04 | +2.86% | 2.44 | -- |  | |
| Pre Market |  | -- | -- | |||||
| CING | Cingulate Inc | | 4.96 | +0.81% | 0.03 | -- |  | |
| Pre Market | | -- | -- | |||||
| IMMX | Immix Biopharma | | 4.96 | +9.73% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| TARA | Protara Therapeutics | | 4.94 | +0.41% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| BCTX | Briacell Therapeutics Corp NEW |  | 4.86 | -55.49% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| RXRX | Recursion Pharmaceuticals | | 4.85 | +3.41% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| AVXL | Anavex Life Sciences Corp | | 4.82 | +3.88% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ABUS | Arbutus Biopharma Corp | | 4.78 | +0.84% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ARTV | Artiva Biotherapeutics Inc | | 4.78 | +3.91% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| NRXS | Neuraxis | | 4.74 | -3.66% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| SANA | Sana Biotechnology | | 4.74 | +0.85% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| TTRX | Turn Therapeutics Inc | | 4.74 | -2.87% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| STTK | Shattuck Labs | | 4.73 | +4.88% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| AGEN | Agenus | | 4.68 | +1.52% | 0.16 | -- | | |
| Pre Market | | -- | -- | |||||
| COYA | Coya Therapeutics | | 4.64 | +0.43% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| TVRD | Tvardi Therapeutics Inc | | 4.63 | +1.54% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ATRA | Atara Biotherapeutics Inc. | | 4.47 | +2.29% | 1.57 | -- | | |
| Pre Market | | -- | -- | |||||
| OBIO | Orchestra BioMed Holdings | | 4.46 | +4.21% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| IMRX | Immuneering Corp | | 4.43 | +7.13% | -- | -- | ||
| Pre Market | | -- | -- | |||||
| PGEN | Precigen | | 4.41 | +5.76% | -- | -- | ||
| Pre Market | | -- | -- | |||||
 | Quotes are at least 15-min delayed：2026/01/15 04:08 EDT |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |